Open Positions
This is the list of the group leaders working in the institutes of the SEMM network, who have open positions.
The number and project descriptions can vary during the application period.
Use the filter below to browse the different projects:
Surname & Name | Research center/University | Research Areas | N. of positions | Title of the project | Description |
---|---|---|---|---|---|
Albanese Manuel |
National Institute of Molecular Genetics (INGM) | Molecular Therapy, Cancer Biology | 1 | Engineered Extracellular Vesicles for personalized leukemia therapy | |
Amati Bruno |
European Institute of Oncology (IEO) | Computational Biology, Cancer Biology | 1 | Unraveling oncogene-drug interactions through computational analysis of transcriptional profiles | |
Bardelli Alberto |
IFOM ETS - The AIRC Institute of Molecular Oncology | Genomic Medicine, Computational Biology | 1 | Immune Engagement and Tumor Evolution in Colorectal Cancer: Biomarker Discovery through Liquid Biopsy and Multi-Omics Approaches | |
Bienko Magda |
Human Technopole (HT) | Molecular and Cellular Biology, Computational Biology | 1 | Unravelling the design principles shaping chromosomal territories | |
Calviello Lorenzo |
Human Technopole (HT) | Molecular and Cellular Biology, Genomic Medicine | 1 | CiliaRNA - RNA regulation and local translation in the ciliary organelle | |
Cavallaro Ugo |
European Institute of Oncology (IEO) | Cancer Biology, Molecular and Cellular Biology | 1 | Crosstalk between tumor vasculature and ovarian cancer stem cells: the new role of L1CAM | |
Cavallaro Ugo |
European Institute of Oncology (IEO) | Cancer Biology, Molecular and Cellular Biology | 1 | The new role of Matrix Gla Protein in ovarian cancer stem cells and in their crosstalk with tumor microenvironment | |
Cosentino Lagomarsino Marco |
IFOM ETS - The AIRC Institute of Molecular Oncology | Molecular and Cellular Biology, Computational Biology | 1 | Single-cell dynamics and cancer persistence | |
Derenzini Enrico |
European Institute of Oncology (IEO) | Molecular Therapy, Immunology | 1 | NK cells immunotherapy in combination with NK-cell engagers for the treatment of aggressive B-cell malignancies | |
Di Mitri Diletta |
Humanitas University | Immunology, Cancer Biology | 1 | Dissection of regional immunity to develop novel immunotherapies against cancer | |
Di Nicolantonio Federica |
University of Turin | Cancer Biology | 1 | The molecular bases of liquid biopsy tests for precision oncology | |
Erdmann Philipp Sebastian |
Human Technopole (HT) | Structural biology | 1 | Genetically Encoded Shape Tags for the Localization of Ciliary Proteins | |
Gauthier Nils |
IFOM ETS - The AIRC Institute of Molecular Oncology | Cancer Biology, Molecular and Cellular Biology | 1 | Intra-patient diversity in Glioblastoma | |
Giustacchini Alice |
Human Technopole (HT) | Cancer Biology, Molecular Therapy | 1 | Engineering Dual-Target CAR T-Cells for Pediatric AML | |
Jereczek Barbara |
European Institute of Oncology (IEO) | Computational Biology | 1 | Investigating the role of new oncological drugs in the high-precision radiotherapy era with a focus on proton therapy (the High-Rad Project) | |
Kalebic Nereo |
Human Technopole (HT) | Neurobiology | 1 | Role of the morphology of neural progenitor cells during brain development | |
Kovatcheva Marta |
IFOM ETS - The AIRC Institute of Molecular Oncology | Cancer Biology, Molecular and Cellular Biology | 1 | Maladaptive cell plasticity in the progression from tissue injury to tumorigenesis | |
Marra Antonio |
European Institute of Oncology (IEO) | Computational Biology, Genomic Medicine | 1 | Multimodal Characterization of Homologous Recombination Deficiency in Hormone Receptor-Positive Early Breast Cancer | |
Marra Antonio |
European Institute of Oncology (IEO) | Genomic Medicine, Computational Biology | 1 | Interception of minimal residual disease in solid malignancies | |
Marsoni Silvia |
IFOM ETS - The AIRC Institute of Molecular Oncology | Computational Biology, Genomic Medicine | 1 | AI-Driven Integromics in Colorectal Cancer | |
Mazzarella Luca |
European Institute of Oncology (IEO) | Genomic Medicine, Structural biology | 1 | Genetic determinants of microtubular damage repair and its impact on cancer treatment and neurodevelopmental disorders | |
Natoli Gioacchino |
European Institute of Oncology (IEO) | Molecular and Cellular Biology | 3 | Mechanisms and functional implications of control of extragenic transcription | |
Natoli Gioacchino |
European Institute of Oncology (IEO) | Computational Biology, Cancer Biology | 1 | Molecular bases and functional implications of cellular heterogeneity in pancreatic cancer | |
Nicassio Francesco |
Center for Genomic Science of IIT | Computational Biology, Genomic Medicine | 1 | Unveiling the RNA Code in Cancer: Long-Read Technologies and AI Models | |
Pasini Diego |
European Institute of Oncology (IEO) | Molecular and Cellular Biology, Cancer Biology | 1 | Regulatory Mechanisms of Polycomb-mediated Transcriptional Repression in the Control of Cell Identity | |
Pesole Graziano |
University of Bari | Computational Biology, Molecular and Cellular Biology | 1 | Charting Tissue-Specific Transcriptome and Epitranscriptome in Humans Through Long-Read Sequencing Data | |
Pigino Gaia |
Human Technopole (HT) | Molecular and Cellular Biology, Structural biology | 1 | Structural and Functional Characterization of Primary Cilia Diversity in Health and Disease | |
Polo Simona |
IFOM ETS - The AIRC Institute of Molecular Oncology | Structural biology, Cancer Biology | 1 | Investigating the supramolecular organization of HECT ubiquitin ligases | |
Sanchini Virginia |
University of Milan | Medical Humanities | 1 | Clinical Ethics in Oncology: Mapping Dilemmas, Conflicts, and Decision-Making Pathways | |
Santaguida Stefano |
European Institute of Oncology (IEO) | Cancer Biology, Molecular and Cellular Biology | 1 | Deciphering and exploiting aneuploidy in cancer | |
Scaffidi Paola |
European Institute of Oncology (IEO) | Molecular and Cellular Biology, Cancer Biology | 2 | Epigenetic mechanisms in health and cancer | |
Scarpa Edoardo |
National Institute of Molecular Genetics (INGM) | Molecular Therapy, Molecular and Cellular Biology | 1 | A senescence-conditional therapy to precisely resect infected cells | |
Segata Nicola |
University of Trento | Computational Biology | 1 | High-resolution computational metagenomics for the study of the transmission of the human microbiome | |
Segata Nicola |
University of Trento | Computational Biology | 1 | Microbiome signatures of early on-set colorectal cancer | |
Soranzo Nicole |
Human Technopole (HT) | Genomic Medicine, Molecular and Cellular Biology | 1 | Discovery and functional dissection of genetic targets of chronic human diseases through the lens of immunology | |
Soskic Blagoje |
Human Technopole (HT) | Immunology, Computational Biology | 1 | Investigating molecular and cellular determinants of B cell differentiation | |
Soskic Blagoje |
Human Technopole (HT) | Cancer Biology, Immunology | 1 | Assembloid platform to model neuro-onco-immune interactions driving NF1 glioma pathology | |
Taverna Elena |
Human Technopole (HT) | Neurobiology, Molecular and Cellular Biology | 1 | Cell biology of brain development | |
Testa Giuseppe |
Human Technopole (HT) | Neurobiology, Computational Biology | 1 | Dissecting the intergenerational and neurodevelopmental impact of environmental perturbations through organoid modelling | |
Vannini Alessandro |
Human Technopole (HT) | Structural biology | 1 | Integrative structural biology of RNA Polymerase III complexes | |
Various PIs at CEINGE |
Center for Genetic Engineering (CEINGE) | Cancer Biology, Genomic Medicine | 1 | TBD | |
Zippo Alessio |
University of Trento | Molecular and Cellular Biology, Cancer Biology | 1 | Epigenetic mechanisms in cancer dormancy | |
Zitti Beatrice |
IFOM ETS - The AIRC Institute of Molecular Oncology | Immunology, Cancer Biology | 1 | Leveraging TRM cells in the tumor microenvironment for improved immunotherapy | |
Zitti Beatrice |
IFOM ETS - The AIRC Institute of Molecular Oncology | Cancer Biology, Immunology | 1 | Leveraging advanced CRISPR/Cas9 screening technologies to investigate tumor response to treatment and its crosstalk with the tumor microenvironment |